SEMAGLUTIDE : ONE THOROUGH EXAMINATION

The novel class of GLP-1 receptor agonist and GIP combined medications, such as tirzepatide, semaglutide, and the newly introduced retatrutide, provide significant progress in metabolic management . Although all three work by influencing blood levels , they vary in their specific mechanisms of ef